Long COVID syndrome and the lung: how long will it last?
Patrick D MitchellJ OlaniyiC BuckleyS C DonnellyPublished in: QJM : monthly journal of the Association of Physicians (2022)
The prevalence and duration of the long-term respiratory complications of COVID-19 infection remains to be elucidated. This short commentary reports on recently published studies in patients post-acute COVID-19 infection in terms of symptom prevalence, physiological and radiological sequela and where only symptoms are present despite investigation. Pulmonary function testing, 6-min walk tests, computed tomography chest and more advanced imaging modalities have been incorporated to reveal the underlying pathophysiology that cause such disabling symptoms in patient with post-acute COVID-9 syndrome (PACS). PACS has a serious impact on people's ability to return to work, affecting the physical, mental, social sphere and with significant healthcare and general economic consequences for them, their families and society.
Keyphrases
- healthcare
- coronavirus disease
- liver failure
- sars cov
- computed tomography
- risk factors
- mental health
- case report
- respiratory failure
- end stage renal disease
- newly diagnosed
- drug induced
- high resolution
- aortic dissection
- positron emission tomography
- magnetic resonance imaging
- patient reported
- depressive symptoms
- magnetic resonance
- adverse drug
- photodynamic therapy
- mass spectrometry
- social media
- health information
- contrast enhanced
- extracorporeal membrane oxygenation
- case control
- pet ct